American Journal of Cardiology
Volume 104, Issue 12 , Pages 1607-1612 , 15 December 2009

Effect of Blood Glucose Concentrations on Admission in Non-Diabetic Versus Diabetic Patients With First Acute Myocardial Infarction on Short- and Long-Term Mortality (from the MONICA/KORA Augsburg Myocardial Infarction Registry)

  • Judith A. Beck

      Affiliations

    • Department of Internal Medicine II - Cardiology, University of Ulm Medical Center, Ulm, Germany
    • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
    • ,
  • Christa Meisinger, MD, MPH

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
    • MONICA/KORA Myocardial Infarction Registry, Central Hospital of Augsburg, Augsburg, Germany
    • Corresponding Author InformationCorresponding author: Tel: 49-821-400-4373; fax: 49-821-400-2838
    • ,
  • Margit Heier, MD

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
    • MONICA/KORA Myocardial Infarction Registry, Central Hospital of Augsburg, Augsburg, Germany
    • ,
  • Bernhard Kuch, MD

      Affiliations

    • Department of Internal Medicine I - Cardiology, Central Hospital of Augsburg, Augsburg, Germany
    • ,
  • Allmut Hörmann

      Affiliations

    • Institute of Health Economics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
    • ,
  • Claudia Greschik

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
    • MONICA/KORA Myocardial Infarction Registry, Central Hospital of Augsburg, Augsburg, Germany
    • ,
  • Wolfgang Koenig, MD

      Affiliations

    • Department of Internal Medicine II - Cardiology, University of Ulm Medical Center, Ulm, Germany

Received 13 May 2009 ,Revised 23 July 2009 ,Accepted 23 July 2009.

References 

  1. Rydén L, Strandl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary—the Task Force of Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88–136
  2. Otter W, Kleybrink S, Doehring W. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med. 2004;21:183–187
  3. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol. 2002;40:1748–1754
  4. Schiele F, Descotes-Genon V, Seronde MF, Blonde C, Legalery P, Meneveau N, et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med. 2006;23:1370–1376
  5. Aronson D, Hammerman H, Kapeliovich MR, Suleiman A, Agmon Y, Beyar R, et al. Fasting glucose in acute myocardial infarction—incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care. 2007;30:960–966
  6. Ainla T, Barburin A, Teesalu R, Rahu M. The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005;22:1321–1325
  7. Goldberg RJ, Kramer DG, Lessard D, Yarzebski J, Gore JM. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis. 2007;18:125–131
  8. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078–3086
  9. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  10. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207–214
  11. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care. 2005;28:2551–2553
  12. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;64:982–988
  13. Meisinger C, Hörmann H, Heier M, Kuch B, Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusions era. Int J Cardiol. 2006;113:229–235
  14. Kuch B, von Scheidt W, Kling B, Heier M, Hörmann A, Meisinger C. Characteristics and outcome of patients with acute myocardial infarction according to presenting electrocardiogram (from the MONICA/KORA Augsburg myocardial infarction – registry). Am J Cardiol. 2007;100:1056–1060
  15. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959–969
  16. Wong VW, Ross DL, Park K, Boyages SC, Cheung NW. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res Clin Pract. 2004;64:85–91
  17. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J. 2003;146:674–678
  18. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart. 2003;89:512–516
  19. Deedwania P, Kosiborod M, Brrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome (A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2008;117:1010–1019
  20. Tansey MJB, Opie LH. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol. 1986;2:326–331
  21. Kosuge M, Kimura K, Kojima S, Sakamoto T, Matsui K, Ishihara M, et al. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circulation. 2005;69:375–379
  22. Norhammar A, Rydén L, Malmberg K. Admission plasma glucose—independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care. 1999;22:1827–1831
  23. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients. Arch Intern Med. 2004;164:2005–2011
  24. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–1334

 The Cooperative Health Research in the Region of Augsburg (KORA) research platform and the Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) Augsburg studies were initiated and financed by Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany, which is funded by the German Federal Ministry of Education, Science, Research and Technology, Berlin, Germany, and by the State of Bavaria. Since 2000, the acquisition of data in acute myocardial infarction patients has been cofinanced by the German Federal Ministry of Health and Social Security, Berlin, Germany, to provide population-based myocardial infarction morbidity and mortality data for the official German Health Reports (http://www.gbe-bund.de).

PII: S0002-9149(09)01471-4

doi: 10.1016/j.amjcard.2009.07.040

American Journal of Cardiology
Volume 104, Issue 12 , Pages 1607-1612 , 15 December 2009

Article Tools

* Image Usage & Resolution